Aprea's Series B Round

Aprea raised a round of funding on March 09, 2016.

Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-cla…

Articles about Aprea's Series B Round: